Neuroinflammation is linked closely
to neurodegenerative diseases,
with reactive oxygen species (ROS) exacerbating neuronal damage. Traditional
electrochemical sensors show promise in targeting cellular ROS to
understand their role in neuropathogenesis and assess therapies. Nevertheless,
these sensors face challenges in mitigating the ROS oxidation overpotential.
We herein introduce an ROS oxidation-independent nucleic acid sensor
for in situ ROS analysis and therapeutic assessment. The sensor comprises
ionizable and thioketal (TK)-based lipids with methylene blue-tagged
nucleic acids on a glass carbon electrode. ROS exposure triggers cleavage
within the sensor’s thioketal moiety, detaching the nucleic
acid from the electrode and yielding quantifiable results via square-wave
voltammetry. Importantly, the sensor’s low potential window
minimizes interference, ensuring precise ROS measurements with high
selectivity. Using this sensor, we unveil levodopa’s dose-dependent
biphasic effect on neuroinflammation: low doses alleviate oxidative
stress, while high doses exacerbate it. The TK-based sensor offers
a promising methodology for investigating neuroinflammation’s
pathogenesis and screening potential treatments, advancing neurodegenerative
disease research